These benefits, together with a previous report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 guidance the concept of targeting ACKR3 as a unique method to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-related disorders. We independently investigate, overview, and https://margareto626hxo2.wikijournalist.com/user